The Immunomodulator AS101 Suppresses Production of Inflammatory Cytokines and Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Journal of Neuroimmunology - Netherlands
doi 10.1016/j.jneuroim.2014.05.015
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2014
Authors
Publisher
Elsevier BV